Skip to main content

Find Clinical Trials

Home
Conditions
Meningitis, Meningococcal

Clinical trial condition

Meningitis, Meningococcal

Explore clinical trials studying Meningitis, Meningococcal. Study availability and eligibility vary by location and protocol.

109 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Meningitis, Meningococcal trial results

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

NCT00422292

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Tuscaloosa, Alabama, United States

Tucson, Arizona, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 88 locations

View Trial Details

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT00384397

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Montgomery, Alabama, United States

Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 39 locations

View Trial Details

Completed

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

NCT02500511

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: IRC Clinics Towson, Maryland, United States

View Trial Details

Completed

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

NCT02305446

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: 01, Novartis Investigational Site Krakow, Poland

View Trial Details

Completed

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

NCT00310817

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: University of Tampere Medical School Tampere, Finland

Oddz. Neuroinfekcji, Szpital Jana Pawla II, Krakow Samodzielny ZOZ, Lubartów, Poland

View Trial Details

Completed

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

NCT01889836

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Unidade de Ensaios Clínicos para Imunobiológicos Rio de Janeiro, Rio de janeiro/RJ, Brazil

View Trial Details

Completed

Safety Surveillance of MenACWY-CRM Vaccine in Children

NCT01452438

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Kaiser Permanente South California Pasadena, California, United States

View Trial Details

Completed

Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

NCT00879814

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Miami Research Associates, Inc. South Miami, Florida, United States

View Trial Details

Completed

A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

NCT01018732

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations: Rochester, Minnesota, United States

Pittsburgh, Pennsylvania, United States

Seattle, Washington, United States

View Trial Details

Completed

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

NCT00161928

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Freistädter Strasse 290 Linz, Austria

Grieskirchner Strasse 17 Wels, Austria

Neuschwansteinstrasse 5 Augsburg, Germany

Marktplatz 3 Bad Saulgau, Germany

View all 14 locations

View Trial Details